Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Reif

Showing results (481-490 of 607) with videos related to

Pageof 61
Sort By:
Neuroscience Applied|April 17, 2026
Weight matters: Higher BMI is associated with changes in the brain connectome in health and depressionAicha Bouzouina, Marius Gruber, Tong Zhao, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 16, 2020
Translating big data to better treatment in bipolar disorder - a manifesto for coordinated actionMirko Manchia, Eduard Vieta, Olav B Smeland, et al.
Brain Sciences|June 28, 2023
Machine Learning Prediction of Estimated Risk for Bipolar Disorders Using Hippocampal Subfield and Amygdala Nuclei VolumesFabian Huth, Leonardo Tozzi, Michael Marxen, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|August 25, 2010
Case-control genome-wide association study of attention-deficit/hyperactivity disorderBenjamin M Neale, Sarah Medland, Stephan Ripke, et al.
Molecular Psychiatry|August 18, 2018
Identification of ADHD risk genes in extended pedigrees by combining linkage analysis and whole-exome sequencingJordi Corominas, Marieke Klein, Tetyana Zayats, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 23, 2021
Therapygenetic effects of 5-HTTLPR on cognitive-behavioral therapy in anxiety disorders: A meta-analysisMiriam A Schiele, Andreas Reif, Jiaxi Lin, et al.
Trials|April 9, 2024
Validation of the predictive value of BDNF -87 methylation for antidepressant treatment success in severely depressed patients-a randomized rater-blinded trialHannah Benedictine Maier, Alexandra Neyazi, Gabriel L Bundies, et al.
Pharmacopsychiatry|November 9, 2023
Prevalence of COVID-19 and Psychotropic Drug Treatment in Psychiatric In-patients in Germany in 2020: Results from a Nationwide Pilot SurveyJuliane K Mueller, Kira F Ahrens, Michael Bauer, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 19, 2026
Psychomotor slowing as a predictor of treatment outcomes in major depressive disorder with acute suicidality: Insights from the OASIS-D studyStefan Fritze, Iris Reinhard, Viktor B Nöhles, et al.
Translational Psychiatry|February 6, 2019
Orexin in the anxiety spectrum: association of a HCRTR1 polymorphism with panic disorder/agoraphobia, CBT treatment response and fear-related intermediate phenotypesMichael G Gottschalk, Jan Richter, Christiane Ziegler, et al.
Pageof 61

Showing results (481-490 of 607) with videos related to

Sort By:
Pageof 61
Neuroscience Applied|April 17, 2026
Weight matters: Higher BMI is associated with changes in the brain connectome in health and depressionAicha Bouzouina, Marius Gruber, Tong Zhao, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 16, 2020
Translating big data to better treatment in bipolar disorder - a manifesto for coordinated actionMirko Manchia, Eduard Vieta, Olav B Smeland, et al.
Brain Sciences|June 28, 2023
Machine Learning Prediction of Estimated Risk for Bipolar Disorders Using Hippocampal Subfield and Amygdala Nuclei VolumesFabian Huth, Leonardo Tozzi, Michael Marxen, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|August 25, 2010
Case-control genome-wide association study of attention-deficit/hyperactivity disorderBenjamin M Neale, Sarah Medland, Stephan Ripke, et al.
Molecular Psychiatry|August 18, 2018
Identification of ADHD risk genes in extended pedigrees by combining linkage analysis and whole-exome sequencingJordi Corominas, Marieke Klein, Tetyana Zayats, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 23, 2021
Therapygenetic effects of 5-HTTLPR on cognitive-behavioral therapy in anxiety disorders: A meta-analysisMiriam A Schiele, Andreas Reif, Jiaxi Lin, et al.
Trials|April 9, 2024
Validation of the predictive value of BDNF -87 methylation for antidepressant treatment success in severely depressed patients-a randomized rater-blinded trialHannah Benedictine Maier, Alexandra Neyazi, Gabriel L Bundies, et al.
Pharmacopsychiatry|November 9, 2023
Prevalence of COVID-19 and Psychotropic Drug Treatment in Psychiatric In-patients in Germany in 2020: Results from a Nationwide Pilot SurveyJuliane K Mueller, Kira F Ahrens, Michael Bauer, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 19, 2026
Psychomotor slowing as a predictor of treatment outcomes in major depressive disorder with acute suicidality: Insights from the OASIS-D studyStefan Fritze, Iris Reinhard, Viktor B Nöhles, et al.
Translational Psychiatry|February 6, 2019
Orexin in the anxiety spectrum: association of a HCRTR1 polymorphism with panic disorder/agoraphobia, CBT treatment response and fear-related intermediate phenotypesMichael G Gottschalk, Jan Richter, Christiane Ziegler, et al.
Pageof 61